These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15383028)

  • 21. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
    Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F
    Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Extracorporeal photopheresis as an alternative therapy for drug-resistant graft versus host disease: three cases].
    D'incan M; Kanold J; Halle P; De Lumley L; Souteyrand P; Deméocq F
    Ann Dermatol Venereol; 2000 Feb; 127(2):166-70. PubMed ID: 10739974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Technology insight: ECP for the treatment of GvHD--can we offer selective immune control without generalized immunosuppression?
    Marshall SR
    Nat Clin Pract Oncol; 2006 Jun; 3(6):302-14. PubMed ID: 16757968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.
    Kaloyannidis P; Mallouri D
    Transfus Apher Sci; 2012 Apr; 46(2):211-9. PubMed ID: 22123355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extracorporeal photopheresis in graft-versus-host disease.
    Carcagnì MR; De Aloe G; D'Ascenzo G; Rubegni P; Fimiani M
    J Dtsch Dermatol Ges; 2008 Jun; 6(6):451-7. PubMed ID: 18177413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracorporeal photopheresis in acute and chronic graft-versus-host disease.
    Greinix HT; Worel N; Just U; Knobler R
    Transfus Apher Sci; 2014 Jun; 50(3):349-57. PubMed ID: 24780392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low-weight children: a novel procedure.
    Schneiderman J; Jacobsohn DA; Collins J; Thormann K; Kletzel M
    J Clin Apher; 2010; 25(2):63-9. PubMed ID: 20301140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal photochemotherapy for steroid-refractory graft-versus-host disease in low-weight pediatric patients. Immunomodulatory effects and clinical outcome.
    González-Vicent M; Ramírez M; Pérez A; Lassaletta A; Sevilla J; Díaz MA
    Haematologica; 2008 Aug; 93(8):1278-80. PubMed ID: 18556405
    [No Abstract]   [Full Text] [Related]  

  • 29. Prognostic factors identifiable at the time of onset of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.
    Remberger M
    Haematologica; 2005 Jul; 90(7):870. PubMed ID: 15996922
    [No Abstract]   [Full Text] [Related]  

  • 30. Extracorporeal photopheresis: the Hellenic experience.
    Dervenoulas J; Tsirigotis P
    Transfus Apher Sci; 2012 Apr; 46(2):169. PubMed ID: 22361574
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades.
    Svahn BM; Ringdén O; Remberger M
    Transplantation; 2006 Jun; 81(11):1600-3. PubMed ID: 16770251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal photopheresis, the Dutch experience.
    Visser O; Schoordijk MC
    Transfus Apher Sci; 2013 Apr; 48(2):167. PubMed ID: 23809818
    [No Abstract]   [Full Text] [Related]  

  • 33. Extracorporeal photophoresis in chronic cutaneous graft-versus-host disease.
    Russell-Jones R
    Bone Marrow Transplant; 1998 Oct; 22(7):621-3. PubMed ID: 9818687
    [No Abstract]   [Full Text] [Related]  

  • 34. Recent compounds for immunosuppression and experimental therapies for acute graft-versus-host disease.
    Michael M; Shimoni A; Nagler A
    Isr Med Assoc J; 2013 Jan; 15(1):44-50. PubMed ID: 23484241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
    Kapadia E; Wong E; Perez-Albuerne E; Jacobsohn D
    Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biology and management of chronic graft-versus-host disease.
    Martin PJ; Pavletic SZ
    Cancer Treat Res; 2009; 144():277-98. PubMed ID: 19779885
    [No Abstract]   [Full Text] [Related]  

  • 37. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
    Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
    Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photopheresis long after the initiation of chronic graft versus host in a child.
    Uygun V; Daloglu H; Karasu G; Yeşilipek A
    Transfus Apher Sci; 2014 Oct; 51(2):172-4. PubMed ID: 25217990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute graft v host disease: developing an extracorporeal photopheresis outreach service.
    Maher T; Taylor P; Alfred A
    Br J Nurs; 2018 May; 27(9):488-492. PubMed ID: 29749783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extracorporeal photochemotherapy: a historical perspective.
    Heshmati F; Andreu G
    Transfus Apher Sci; 2003 Feb; 28(1):25-34. PubMed ID: 12620266
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.